My Quote Request
6505-01-371-8322
20 Products
PAXIL
PAROXETINE HYDROCHL
NSN, MFG P/N
6505013718322
NSN
6505-01-371-8322
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 20 MG.; UNIT OF USE; ROUND; SCORED; PINK COLOR; SHELF POTENCY PERIOD OF 36 MONTHS; 100 TABS/BT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PAROXETINE HYDROCHLORIDE TABLETS 20MG 100S BT
Related Searches:
321113
PAROXETINE HYDROCHL
NSN, MFG P/N
6505013718323
NSN
6505-01-371-8323
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 20 MG.; UNIT OF USE; ROUND; SCORED; PINK COLOR; SHELF POTENCY PERIOD OF 36 MONTHS; 30 TABS/BT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PAROXETINE HYDROCHLORIDE TABLETS 20MG 30S BT
Related Searches:
NDC00029-3211-13
PAROXETINE HYDROCHL
NSN, MFG P/N
6505013718323
NSN
6505-01-371-8323
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 20 MG.; UNIT OF USE; ROUND; SCORED; PINK COLOR; SHELF POTENCY PERIOD OF 36 MONTHS; 30 TABS/BT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PAROXETINE HYDROCHLORIDE TABLETS 20MG 30S BT
Related Searches:
PAXIL
PAROXETINE HYDROCHL
NSN, MFG P/N
6505013718323
NSN
6505-01-371-8323
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 20 MG.; UNIT OF USE; ROUND; SCORED; PINK COLOR; SHELF POTENCY PERIOD OF 36 MONTHS; 30 TABS/BT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PAROXETINE HYDROCHLORIDE TABLETS 20MG 30S BT
Related Searches:
NDC00087-5650-41
BUTORPHANOL TARTRATE NASAL SOLUTION
NSN, MFG P/N
6505013718384
NSN
6505-01-371-8384
NDC00087-5650-41
BUTORPHANOL TARTRATE NASAL SOLUTION
NSN, MFG P/N
6505013718384
NSN
6505-01-371-8384
MFG
BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS BUTORPHANOL TARTRATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUTORPHANOL TARTRATE NASAL SOLUTION 10MG/LML 2.5ML BT
SPECIAL FEATURES: 2.5 ML BT OF SOLUTION W/SPRAY PUMP; CLASS 4
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
STADOL NS
BUTORPHANOL TARTRATE NASAL SOLUTION
NSN, MFG P/N
6505013718384
NSN
6505-01-371-8384
STADOL NS
BUTORPHANOL TARTRATE NASAL SOLUTION
NSN, MFG P/N
6505013718384
NSN
6505-01-371-8384
MFG
BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS BUTORPHANOL TARTRATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUTORPHANOL TARTRATE NASAL SOLUTION 10MG/LML 2.5ML BT
SPECIAL FEATURES: 2.5 ML BT OF SOLUTION W/SPRAY PUMP; CLASS 4
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
86430
SIMETHICONE TABLETS,USP
NSN, MFG P/N
6505013719633
NSN
6505-01-371-9633
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS DIMETHICONE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SIMETHICONE TABLETS USP 80MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
F93A346
SIMETHICONE TABLETS,USP
NSN, MFG P/N
6505013719633
NSN
6505-01-371-9633
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS DIMETHICONE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SIMETHICONE TABLETS USP 80MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00182-8643-89
SIMETHICONE TABLETS,USP
NSN, MFG P/N
6505013719633
NSN
6505-01-371-9633
NDC00182-8643-89
SIMETHICONE TABLETS,USP
NSN, MFG P/N
6505013719633
NSN
6505-01-371-9633
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS DIMETHICONE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SIMETHICONE TABLETS USP 80MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
F93A339
BERACTANT INTRATRACHEAL SUSPENSION
NSN, MFG P/N
6505013720173
NSN
6505-01-372-0173
F93A339
BERACTANT INTRATRACHEAL SUSPENSION
NSN, MFG P/N
6505013720173
NSN
6505-01-372-0173
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS PHOSPHOLIPIDS PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BERACTANT INTRATRACHEAL SUSPENSION 8ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: USED FOR PREVENTION AND TREATMENT OF RDS(HYALINE MEMBRANE DISEASE)IN PREMATURE INFANTS;NOTE:G;NOT FOR INJECTION
Related Searches:
NDC00074-1040-08
BERACTANT INTRATRACHEAL SUSPENSION
NSN, MFG P/N
6505013720173
NSN
6505-01-372-0173
NDC00074-1040-08
BERACTANT INTRATRACHEAL SUSPENSION
NSN, MFG P/N
6505013720173
NSN
6505-01-372-0173
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS PHOSPHOLIPIDS PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BERACTANT INTRATRACHEAL SUSPENSION 8ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: USED FOR PREVENTION AND TREATMENT OF RDS(HYALINE MEMBRANE DISEASE)IN PREMATURE INFANTS;NOTE:G;NOT FOR INJECTION
Related Searches:
SURVANTA
BERACTANT INTRATRACHEAL SUSPENSION
NSN, MFG P/N
6505013720173
NSN
6505-01-372-0173
SURVANTA
BERACTANT INTRATRACHEAL SUSPENSION
NSN, MFG P/N
6505013720173
NSN
6505-01-372-0173
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS PHOSPHOLIPIDS PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BERACTANT INTRATRACHEAL SUSPENSION 8ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: USED FOR PREVENTION AND TREATMENT OF RDS(HYALINE MEMBRANE DISEASE)IN PREMATURE INFANTS;NOTE:G;NOT FOR INJECTION
Related Searches:
3001-02
UREA CREAM
NSN, MFG P/N
6505013721291
NSN
6505-01-372-1291
MFG
DERCHER ENTERPRISES INC DBA GORDON LABORATORIES
Description
ACTIVE INGREDIENT AND STRENGTH: 20.000 UREA PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 OUNCES
PRIMARY CONTAINER TYPE: JAR
SPECIAL FEATURES: 2.5 OZ (70.87 GM); 12 PLASTIC JARS PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
GORMEL
UREA CREAM
NSN, MFG P/N
6505013721291
NSN
6505-01-372-1291
MFG
DERCHER ENTERPRISES INC DBA GORDON LABORATORIES
Description
ACTIVE INGREDIENT AND STRENGTH: 20.000 UREA PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 OUNCES
PRIMARY CONTAINER TYPE: JAR
SPECIAL FEATURES: 2.5 OZ (70.87 GM); 12 PLASTIC JARS PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
GORMEL CREAM
UREA CREAM
NSN, MFG P/N
6505013721291
NSN
6505-01-372-1291
MFG
DERCHER ENTERPRISES INC DBA GORDON LABORATORIES
Description
ACTIVE INGREDIENT AND STRENGTH: 20.000 UREA PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 OUNCES
PRIMARY CONTAINER TYPE: JAR
SPECIAL FEATURES: 2.5 OZ (70.87 GM); 12 PLASTIC JARS PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC10481-3001-02
UREA CREAM
NSN, MFG P/N
6505013721291
NSN
6505-01-372-1291
MFG
DERCHER ENTERPRISES INC DBA GORDON LABORATORIES
Description
ACTIVE INGREDIENT AND STRENGTH: 20.000 UREA PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 OUNCES
PRIMARY CONTAINER TYPE: JAR
SPECIAL FEATURES: 2.5 OZ (70.87 GM); 12 PLASTIC JARS PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
2B0163Q
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013723422
NSN
6505-01-372-3422
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 500ML PLASTIC BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: SINGLE DOSE; TRANSPARENT, FLEXIBLE BAG, W/TWO PERMANENTLY ATTACHED OUTLET PORTS; FOR USE W/INTRAVENOUS INJ SETS, 6515-00-115-0032, 6515-00-140-0888 AND 6515-00-433-2089
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
7930-03
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013723422
NSN
6505-01-372-3422
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 500ML PLASTIC BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: SINGLE DOSE; TRANSPARENT, FLEXIBLE BAG, W/TWO PERMANENTLY ATTACHED OUTLET PORTS; FOR USE W/INTRAVENOUS INJ SETS, 6515-00-115-0032, 6515-00-140-0888 AND 6515-00-433-2089
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
L5201
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013723422
NSN
6505-01-372-3422
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 500ML PLASTIC BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: SINGLE DOSE; TRANSPARENT, FLEXIBLE BAG, W/TWO PERMANENTLY ATTACHED OUTLET PORTS; FOR USE W/INTRAVENOUS INJ SETS, 6515-00-115-0032, 6515-00-140-0888 AND 6515-00-433-2089
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00338-0023-03
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013723422
NSN
6505-01-372-3422
NDC00338-0023-03
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013723422
NSN
6505-01-372-3422
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 500ML PLASTIC BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: SINGLE DOSE; TRANSPARENT, FLEXIBLE BAG, W/TWO PERMANENTLY ATTACHED OUTLET PORTS; FOR USE W/INTRAVENOUS INJ SETS, 6515-00-115-0032, 6515-00-140-0888 AND 6515-00-433-2089
TOTAL PRIMARY CONTAINER QUANTITY: 24